Published in CMAJ on December 10, 2008
Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician (2009) 1.40
Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. Circ Res (2009) 1.16
Prescription pattern of chinese herbal products for diabetes mellitus in taiwan: a population-based study. Evid Based Complement Alternat Med (2013) 1.05
Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management? Bone (2009) 1.04
Double-blind, placebo-controlled clinical evaluation of an Ayurvedic formulation (GlucoCare capsules) in non-insulin dependent diabetes mellitus. J Ayurveda Integr Med (2010) 0.89
Clustering of the metabolic syndrome components in adolescence: role of visceral fat. PLoS One (2013) 0.79
Safety and efficacy of rosiglitazone in the elderly diabetic patient. Vasc Health Risk Manag (2009) 0.76
Thiazolidinedione use and the risk of fractures. CMAJ (2009) 0.75
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med (2007) 33.21
Thiazolidinediones. N Engl J Med (2004) 9.42
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. JAMA (2007) 5.89
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet (2007) 5.74
Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis. JAMA (2007) 5.02
Thiazolidinediones and cardiovascular outcomes in older patients with diabetes. JAMA (2007) 4.25
Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ (2008) 3.56